ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Long-Term Debt
ADC Therapeutics SA
Long-Term Debt Peer Comparison
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Long-Term Debt
$416.3m
|
CAGR 3-Years
124%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Long-Term Debt
CHf2.8m
|
CAGR 3-Years
16%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Long-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Long-Term Debt
CHf95.5m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Long-Term Debt
CHf1.1B
|
CAGR 3-Years
25%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Long-Term Debt
CHf1.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Long-Term Debt?
Long-Term Debt
416.3m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Long-Term Debt amounts to 416.3m USD.
What is ADC Therapeutics SA's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
124%
Over the last year, the Long-Term Debt growth was 32%. The average annual Long-Term Debt growth rates for ADC Therapeutics SA have been 124% over the past three years .